Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations.

Kim T, Bimler L, Ronzulli SL, Song AY, Johnson SK, Jones CA, Tompkins SM, Paust S.

Open source

DOI
10.1126/sciadv.adx3505
Published
2025-09-10
Container
Sci Adv
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1126/sciadv.adx3505,
  title = {Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations.},
  author = {Kim T and  Bimler L and  Ronzulli SL and  Song AY and  Johnson SK and  Jones CA and  Tompkins SM and  Paust S.},
  year = {2025},
  journal = {Sci Adv},
  doi = {10.1126/sciadv.adx3505},
  url = {https://doi.org/10.1126/sciadv.adx3505}
}

RIS

TY  - JOUR
TI  - Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations.
AU  - Kim T
AU  -  Bimler L
AU  -  Ronzulli SL
AU  -  Song AY
AU  -  Johnson SK
AU  -  Jones CA
AU  -  Tompkins SM
AU  -  Paust S.
PY  - 2025
JO  - Sci Adv
DO  - 10.1126/sciadv.adx3505
UR  - https://doi.org/10.1126/sciadv.adx3505
ER  - 

APA

T, K., L, B., SL, R., AY, S., SK, J., CA, J., SM, T., & S., P. (2025). Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations.. Sci Adv. https://doi.org/10.1126/sciadv.adx3505

Source records